Related Experiment Videos
Relationships between homocysteine and related amino acids in chronic hemodialysis patients
S P McDonald1, M J Whiting, G A Tallis
1Department of Biochemistry, Flinders Medical Centre, Adelaide, Australia. stephenm@menzies.edu.au
Insights
High folic acid supplementation may help manage elevated homocysteine levels in dialysis patients. This study found an inverse relationship between red blood cell folate and homocysteine, suggesting a therapeutic role for high-dose folate.
Area of Science:
- Nephrology
- Cardiovascular Disease
- Nutritional Biochemistry
Background:
- Elevated homocysteine (Hcy) is a risk factor for atherosclerotic disease.
- Chronic dialysis patients exhibit high Hcy levels, contributing to vascular mortality.
- Limited data exists on related amino acid levels in this patient group.
Purpose of the Study:
- To document homocysteine and related amino acid levels in hemodialysis patients.
- To investigate the relationship between folate, vitamin B12, and Hcy in this population.
- To explore amino acid changes pre- and post-dialysis.
Main Methods:
- Observational study of 114 hemodialysis patients.
- Measured pre-dialysis total plasma homocysteine, vitamin B12, and red blood cell (RBC) folate.
- Analyzed other plasma amino acids in a subgroup (n=42) pre- and post-dialysis.
Main Results:
- All patients had elevated Hcy (mean 33.1 umol/l).
- High RBC folate levels were inversely related to Hcy (r = -0.44, p < 0.001).
- Low serine levels were observed and related to elevated Hcy (r = 0.42, p < 0.01).
Conclusions:
- High-dose folic acid supplementation may treat renal-failure related hyperhomocysteinemia.
- Low serine levels are expected due to kidney synthesis; serine supplements may not impact Hcy.
- Dialysis effectively reduces Hcy levels (mean 33% reduction).
Aims:
Homocysteine (Hcy) has emerged as an important risk factor for atherosclerotic disease. Elevated levels in chronic dialysis patients may contribute to high vascular mortality, but little is known about levels of related amino acids in this group. In an observational study in the clinical setting we sought to document these.
Methods:
In 114 hemodialysis patients pre-dialysis total plasma homocysteine, vitamin B12 and red blood cell (RBC) folate concentrations were measured. In a subgroup of patients (n = 42), other plasma amino acids were measured pre- and post-dialysis. All patients were routinely taking oral folic acid supplements (1.2 mg per week).
Results:
Elevated homocysteine concentrations were found in all patients (geometric mean 33.1 umol/l, range 13.8 - 69.2 umol/l, laboratory reference range (RR) 3-13 umol/l). RBC folate levels were high (1223 +/- 54.5 nmol/l mean +/- SE, RR 300 - 710 nmol/l) and inversely related to pre-dialysis plasma Hcy (r = -0.44, p < 0.001). Hcy levels were not related to vitamin B12 levels. A history of vascular disease was not associated with higher concentrations of Hcy. Hcy clearance on dialysis was substantial (mean Hcy reduction 33 +/- 14%). While plasma methionine levels were normal, serine levels were significantly lower than the reference range (59.3 +/- 2.39 umol/l (mean +/- SE, RR 70 - 195 umol/l)) and directly related to levels of glycine (r = 0.52, p < 0.001). Glycine levels were within normal range. Although overall levels were low, higher serine levels were related to elevated homocysteine (r = 0.42, p < 0.01). Dialytic loss of glycine, serine and methionine was moderate.
Conclusion:
An inverse association between RBC folate and homocysteine levels extended to 3 times the upper limit of normal for folate, suggesting a role for high dose folic acid supplementation in the treatment of renal-failure related hyperhomocysteinemia. Low serine levels are expected as it is primarily synthesized in the kidney. The direct relationship between serine and homocysteine is consistent with the reported lack of effect of serine supplements on high Hcy levels.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemodialysis II: Procedure and Complications
Chronic Kidney Disease II: Clinical Manifestations
Hemodialysis III: Nursing Management
Chronic Kidney Disease I: Introduction